Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 716   Home Print this page  Email this page Small font size Default font size Increase font size

    Article Cited by others

REVIEW ARTICLE

DOTS for TB relapse in India: A systematic review

Azhar Gulrez Shah

Year : 2012| Volume: 29| Issue : 2 | Page no: 147-153

   This article has been cited by
 
1 Development and optimization of polymeric nanoparticles of antitubercular drugs using central composite factorial design
Chawla, R., Jaiswal, S., Mishra, B.
Lung India. 2014; 11(1): 31-43
[Pubmed]  [Google Scholar]
2 Development and optimization of polymeric nanoparticles of antitubercular drugs using central composite factorial design*
Ruchi Chawla,Swati Jaiswal,Brahmeshwar Mishra
Expert Opinion on Drug Delivery. 2013; : 1
[Pubmed]  [Google Scholar] [DOI]
3 High relapse rate in RNTCP: An increasing concern and time to intervene
De, S.
Lung India. 2013; 30(1): 85-86
[Pubmed]  [Google Scholar]
4 Is the directly observed therapy short course (DOTS) an effective strategy for tuberculosis control in a developing country?
Otu, A.A.
Asian Pacific Journal of Tropical Disease. 2013; 3(3): 227-231
[Pubmed]  [Google Scholar]

 

Read this article